Legis Daily

Interagency Patent Coordination and Improvement Act of 2023

USA118th CongressHR-1717| House 
| Updated: 3/22/2023
Joe Neguse

Joe Neguse

Democratic Representative

Colorado

Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Interagency Patent Coordination and Improvement Act of 2023 This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the PTO, and (3) the PTO to assist the FDA in its ministerial role of listing patents.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 1, 2023

Latest Companion Bill Action

S 118-79
Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
Mar 22, 2023
Introduced in House
Mar 22, 2023
Referred to the House Committee on the Judiciary.
  • March 1, 2023

    Latest Companion Bill Action

    S 118-79
    Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.


  • March 22, 2023
    Introduced in House


  • March 22, 2023
    Referred to the House Committee on the Judiciary.

Commerce

Related Bills

  • S 118-79: Interagency Patent Coordination and Improvement Act of 2023

Interagency Patent Coordination and Improvement Act of 2023

USA118th CongressHR-1717| House 
| Updated: 3/22/2023
Interagency Patent Coordination and Improvement Act of 2023 This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the PTO, and (3) the PTO to assist the FDA in its ministerial role of listing patents.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 1, 2023

Latest Companion Bill Action

S 118-79
Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
Mar 22, 2023
Introduced in House
Mar 22, 2023
Referred to the House Committee on the Judiciary.
  • March 1, 2023

    Latest Companion Bill Action

    S 118-79
    Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.


  • March 22, 2023
    Introduced in House


  • March 22, 2023
    Referred to the House Committee on the Judiciary.
Joe Neguse

Joe Neguse

Democratic Representative

Colorado

Judiciary Committee

Commerce

Related Bills

  • S 118-79: Interagency Patent Coordination and Improvement Act of 2023
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted